Sangamo Therapeutics
SGMO
#10618
Rank
NZ$54.62 M
Marketcap
NZ$0.13
Share price
0.00%
Change (1 day)
-88.74%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -NZ$0.19 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are NZ$34.55 Million. In 2025 the company made an earning of -NZ$0.2 Billion a decrease over its 2024 earnings that were of -NZ$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.19 Billion-1.66%
2025 -NZ$0.2 Billion9.71%
2024 -NZ$0.18 Billion-17.27%
2023 -NZ$0.22 Billion-40.88%
2022 -NZ$0.36 Billion9.79%
2021 -NZ$0.33 Billion41.52%
2020 -NZ$0.24 Billion23.17%
2019 -NZ$0.19 Billion36.33%
2018 -NZ$0.14 Billion36.89%
2017 -NZ$0.11 Billion-22.32%
2016 -NZ$0.13 Billion54.86%
2015 -NZ$83.5 Million75.62%
2014 -NZ$47.55 Million0.13%
2013 -NZ$47.49 Million
2011 -NZ$63.83 Million43.66%
2010 -NZ$44.44 Million28.52%
2009 -NZ$34.58 Million-23.55%
2008 -NZ$45.23 Million2.45%
2007 -NZ$44.14 Million19.5%
2006 -NZ$36.94 Million50.78%
2005 -NZ$24.5 Million75%
2004 -NZ$14 Million-33.25%
2003 -NZ$20.98 Million-62.27%
2002 -NZ$55.59 Million102.82%
2001 -NZ$27.41 Million23.21%
2000 -NZ$22.25 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$46.70 B-23,855.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$18.33 B-9,424.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$1.80 B-1,016.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-NZ$1.78 Billion 803.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-NZ$3.49 Billion 1,672.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.70 B-7,070.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$2.00 B-1,119.42%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.26 B-235.16%๐Ÿ‡บ๐Ÿ‡ธ USA